Identification and application of human amniotic mesenchymal stem cell exocrine protein POSTN
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 中国医科大学
- Publication Date
- 2021-08-17
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biotechnology, in particular to the identification and application of human amniotic mesenchymal stem cell exocrine protein-periostin (POSTN). Background technique
[0002] Mesenchymal stem cells (MSCs) have been shown to secrete various autocrine / paracrine factors, including growth factors and cytokines, which play a major role in cell therapy. Human amniotic membranes are often discarded as biological waste after childbirth and become an important source of amniotic mesenchymal stem cells (hAMSCs). In addition, it has many other advantages such as anti-inflammatory, antibacterial, anti-angiogenic properties and low immunogenicity. HAMSC-secreted factors for cell-free therapy of acute brain injury. We found many proteins related to cell proliferation in hAMSCs conditioned medium (hAMSCs-CM).
[0003] Periostin (POSTN) is an extracellular matrix protein composed of 836 amino acids and about 90kD in size. POSTN ...